Literature DB >> 33063920

Magnetic Resonance Signal Amplification by Reversible Exchange of Selective PyFALGEA Oligopeptide Ligands Towards Epidermal Growth Factor Receptors.

Tomasz Ratajczyk1, Gerd Buntkowsky2, Torsten Gutmann2, Bartłomiej Fedorczyk3,4, Adam Mames1, Mariusz Pietrzak1, Zuzanna Puzio5, Piotr Grzegorz Szkudlarek6.   

Abstract

The biorelevant PyFALGEA oligopeptide ligand, which is selective towards the epidermal growth factor receptor (EGFR), has been successfully employed as a substrate in magnetic resonance signal amplification by reversible exchange (SABRE) experiments. It is demonstrated that PyFALGEA and the iridium catalyst IMes form a PyFALGEA:IMes molecular complex. The interaction between PyFALGEA:IMes and H2 results in a ternary SABRE complex. Selective 1D EXSY experiments reveal that this complex is labile, which is an essential condition for successful hyperpolarization by SABRE. Polarization transfer from parahydrogen to PyFALGEA is observed leading to significant enhancement of the 1 H NMR signals of PyFALGEA. Different iridium catalysts and peptides are inspected to discuss the influence of their molecular structures on the efficiency of hyperpolarization. It is observed that PyFALGEA oligopeptide hyperpolarization is more efficient when an iridium catalyst with a sterically less demanding NHC ligand system such as IMesBn is employed. Experiments with shorter analogues of PyFALGEA, that is, PyLGEA and PyEA, show that the bulky phenylalanine from the PyFALGEA oligopeptide causes steric hindrance in the SABRE complex, which hampers hyperpolarization with IMes. Finally, a single-scan 1 H NMR SABRE experiment of PyFALGEA with IMesBn revealed a unique pattern of NMR lines in the hydride region, which can be treated as a fingerprint of this important oligopeptide.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  NMR spectroscopy; SABRE; epidermal growth factor receptors; hyperpolarization; tyrosine kinases

Year:  2020        PMID: 33063920     DOI: 10.1002/cbic.202000711

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  7 in total

1.  Parahydrogen Hyperpolarization Allows Direct NMR Detection of α-Amino Acids in Complex (Bio)mixtures.

Authors:  Lisanne Sellies; Ruud L E G Aspers; Martin C Feiters; Floris P J T Rutjes; Marco Tessari
Journal:  Angew Chem Int Ed Engl       Date:  2021-11-18       Impact factor: 16.823

Review 2.  Advancing homogeneous catalysis for parahydrogen-derived hyperpolarisation and its NMR applications.

Authors:  Ben J Tickner; Vladimir V Zhivonitko
Journal:  Chem Sci       Date:  2022-03-22       Impact factor: 9.969

3.  Deactivation of catalysts in simultaneous reversible and irreversible parahydrogen NMR signal enhancement, and the role of co-ligands in the stabilization of the reversible method.

Authors:  Adam Mames; Sylwia Jopa; Mariusz Pietrzak; Tomasz Ratajczyk
Journal:  RSC Adv       Date:  2022-05-27       Impact factor: 4.036

4.  A disintegrin derivative as a case study for PHIP labeling of disulfide bridged biomolecules.

Authors:  Max Fleckenstein; Kevin Herr; Franziska Theiß; Stephan Knecht; Laura Wienands; Martin Brodrecht; Michael Reggelin; Gerd Buntkowsky
Journal:  Sci Rep       Date:  2022-02-11       Impact factor: 4.379

5.  Understanding Parahydrogen Hyperpolarized Urine Spectra: The Case of Adenosine Derivatives.

Authors:  Kerti Ausmees; Nele Reimets; Indrek Reile
Journal:  Molecules       Date:  2022-01-26       Impact factor: 4.411

Review 6.  Recent advances in the application of parahydrogen in catalysis and biochemistry.

Authors:  Gerd Buntkowsky; Franziska Theiss; Jonas Lins; Yuliya A Miloslavina; Laura Wienands; Alexey Kiryutin; Alexandra Yurkovskaya
Journal:  RSC Adv       Date:  2022-04-26       Impact factor: 4.036

Review 7.  Parahydrogen-Induced Polarization of Amino Acids.

Authors:  Andrey N Pravdivtsev; Gerd Buntkowsky; Simon B Duckett; Igor V Koptyug; Jan-Bernd Hövener
Journal:  Angew Chem Int Ed Engl       Date:  2021-08-13       Impact factor: 15.336

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.